2,815
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

m6A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury

, , &
Pages 5443-5452 | Received 16 Dec 2021, Accepted 04 Jan 2022, Published online: 17 Feb 2022

References

  • Carbone F, Bonaventura A, Montecucco F. Neutrophil-related oxidants drive heart and brain remodeling after ischemia/reperfusion injury. Front Physiol. 2019;10:1587.
  • Chong J, Bulluck H, Fw Ho A, et al. Chronic remote ischemic conditioning for cardiovascular protection. Conditioning medicine. 2019;2(4):164–169.
  • Edupuganti MM, Ganga V. Acute myocardial infarction in pregnancy: current diagnosis and management approaches. Indian Heart J. 2019;71(5):367–374.
  • Iannattone PA, Zhao X, VanHouten J, et al. Artificial intelligence for diagnosis of acute coronary syndromes: a meta-analysis of machine learning approaches. Can J Cardiol. 2020;36(4):577–583.
  • Guo J, Zheng J, Zhang H, et al. RNA m6A methylation regulators in ovarian cancer. Cancer Cell Int. 2021;21(1):609.
  • Issah MA, Wu D, Zhang F, et al. Epigenetic modifications in acute myeloid leukemia: the emerging role of circular RNAs (Review). Int J Oncol. 2021;59(6). DOI:10.3892/ijo.2021.5287.
  • Zhang Z, Wei W, Wang H, et al. N6-methyladenosine-sculpted regulatory landscape of noncoding RNA. Front Oncol. 2021;11:743990.
  • Zhao X, Yang L, Qin L. Methyltransferase-like 3 (METTL3) attenuates cardiomyocyte apoptosis with myocardial ischemia-reperfusion (I/R) injury through miR-25-3p and miR-873-5p. Cell Biol Int. 2021. DOI:10.1002/cbin.11706
  • Zhuang S, Ma Y, Zeng Y, et al. METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. 2021. DOI:10.1007/s10565-021-09660-7.
  • Zheng QK, Ma C, Ullah I, et al. Roles of N6-methyladenosine demethylase FTO in malignant tumors progression. Onco Targets Ther. 2021;14:4837–4846.
  • Zhou LL, Xu H, Huang Y, et al. Targeting the RNA demethylase FTO for cancer therapy. RSC chemical biology. 2021;2(5):1352–1369.
  • Zhou YY, Wang SQ, Zhu WZ, et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol. 2000;279(1):H429–436.
  • Mahmoud AI, Kocabas F, Muralidhar SA, et al. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature. 2013;497(7448):249–253.
  • Li Y, Ren S, Xia J, et al. EIF4A3-Induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3. Mol Ther Nucleic Acids. 2020;19:533–545.
  • Cai WF, Wang L, Liu GS, et al. Manipulating the Hippo-Yap signal cascade in stem cells for heart regeneration. Ann Palliat Med. 2016;5(2):125–134.
  • Flinn MA, Link BA, O’Meara CC. Upstream regulation of the Hippo-Yap pathway in cardiomyocyte regeneration. Semin Cell Dev Biol. 2020;100:11–19.
  • Chen C, Guo Y, Guo Y, et al. m6A modification in non-coding RNA: the role in cancer drug resistance. Front Oncol. 2021;11:746789.
  • Wang X, Ma R, Zhang X, et al. Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions. Mol Cancer. 2021;20(1):121.
  • Shen W, Li H, Su H, et al. FTO overexpression inhibits apoptosis of hypoxia/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt. Mol Cell Biochem. 2021;476(5):2171–2179.